The Treatment of Clear Cell Ovarian Cancer with the Poly(ADP- Ribose) Polymerase (PARP1) Inhibitors (AG14361,Veliparib,Olaparib) as Chemosensitizers.
This study tests the effectiveness of PARP inhibitors as chemosensitizers for clear cell ovarian cancer, finding they enhance sensitivity to several chemotherapy agents.
bioRxiv · Mar 28, 2020Pharmacology & Toxicology